Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00678327
Recruitment Status : Active, not recruiting
First Posted : May 15, 2008
Last Update Posted : January 26, 2018
Cancer Research UK
Cancer Research UK & UCL Cancer Trials Centre
Information provided by (Responsible Party):
University College, London